MoneyWorks4Me

Concord Drugs - Quaterly Results

08 Aug 2025 Evaluate
The Total revenue for the quarter ended June 2025 of  Rs. 133.84 millions grew by 110.67% from Rs. 63.53 millions.Net Profit for the quarter ended June 2025 zoomed to 833.33% from Rs. 0.12 millions to Rs. 1.12  millions.Operating profit surged to 9.39 millions from the corresponding previous quarter of 7.32 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 133.84 63.53 110.67 133.84 63.53 110.67 369.46 432.70 -14.62
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 9.39 7.32 28.28 9.39 7.32 28.28 37.77 36.87 2.44
Interest 4.20 3.70 13.51 4.20 3.70 13.51 17.18 15.90 8.05
PBDT 5.19 3.62 43.37 5.19 3.62 43.37 20.59 20.97 -1.81
Depreciation 3.66 3.35 9.25 3.66 3.35 9.25 14.18 15.38 -7.80
PBT 1.53 0.27 466.67 1.53 0.27 466.67 6.41 5.59 14.67
TAX 0.41 0.15 173.33 0.41 0.15 173.33 3.46 1.39 148.92
Deferred Tax -0.11 -0.09 22.22 -0.11 -0.09 22.22 1.56 -0.63 -347.62
PAT 1.12 0.12 833.33 1.12 0.12 833.33 2.95 4.20 -29.76
Equity 100.00 100.00 0.00 100.00 100.00 0.00 100.00 100.00 0.00
PBIDTM(%) 7.02 11.52 -39.11 7.02 11.52 -39.11 10.22 8.52 19.98
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..